Concepts (242)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 2 | 2017 | 4 | 1.45 | Why? |
| Single-Chain Antibodies | 1 | 2020 | 259 | 0.72 | Why? |
| Virus Assembly | 1 | 2020 | 438 | 0.67 | Why? |
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 112 | 0.63 | Why? |
| Pancreatic Neoplasms | 3 | 2017 | 609 | 0.61 | Why? |
| Hand, Foot and Mouth Disease | 1 | 2017 | 115 | 0.59 | Why? |
| Enterovirus A, Human | 1 | 2017 | 180 | 0.56 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.56 | Why? |
| Ebolavirus | 2 | 2018 | 834 | 0.55 | Why? |
| Glycoproteins | 1 | 2018 | 615 | 0.52 | Why? |
| Influenza in Birds | 5 | 2019 | 528 | 0.50 | Why? |
| Biomarkers, Tumor | 2 | 2017 | 1314 | 0.44 | Why? |
| Chemokines | 1 | 2017 | 1095 | 0.42 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.37 | Why? |
| Octamer Transcription Factor-3 | 2 | 2018 | 17 | 0.37 | Why? |
| Viral Proteins | 5 | 2020 | 7370 | 0.37 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.36 | Why? |
| Epitopes | 1 | 2020 | 4113 | 0.35 | Why? |
| MicroRNAs | 2 | 2017 | 1787 | 0.34 | Why? |
| Reassortant Viruses | 3 | 2018 | 287 | 0.32 | Why? |
| Antibodies, Neutralizing | 5 | 2021 | 25288 | 0.29 | Why? |
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 372 | 0.28 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2019 | 511 | 0.27 | Why? |
| Orthomyxoviridae Infections | 4 | 2018 | 1001 | 0.25 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.23 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.22 | Why? |
| Influenza A Virus, H7N9 Subtype | 2 | 2018 | 415 | 0.22 | Why? |
| Amino Acid Substitution | 2 | 2019 | 1706 | 0.22 | Why? |
| Dibenzothiepins | 1 | 2020 | 39 | 0.22 | Why? |
| Influenza A virus | 3 | 2018 | 2234 | 0.22 | Why? |
| Poultry Diseases | 2 | 2018 | 588 | 0.21 | Why? |
| Influenzavirus A | 1 | 2019 | 66 | 0.19 | Why? |
| Mice, Inbred BALB C | 6 | 2018 | 5814 | 0.19 | Why? |
| Birds | 2 | 2019 | 412 | 0.19 | Why? |
| Methylene Blue | 1 | 2021 | 175 | 0.19 | Why? |
| Morpholines | 1 | 2020 | 351 | 0.18 | Why? |
| Cell Line, Tumor | 5 | 2018 | 3608 | 0.18 | Why? |
| Transcription Factor AP-1 | 1 | 2018 | 75 | 0.18 | Why? |
| Triazines | 1 | 2020 | 246 | 0.18 | Why? |
| Proto-Oncogene Proteins c-met | 1 | 2017 | 40 | 0.17 | Why? |
| Mitogen-Activated Protein Kinases | 1 | 2017 | 126 | 0.17 | Why? |
| Calcium Channels | 1 | 2017 | 96 | 0.17 | Why? |
| Influenza A Virus, H5N8 Subtype | 1 | 2017 | 50 | 0.17 | Why? |
| Deoxycytidine | 1 | 2017 | 116 | 0.16 | Why? |
| Antimetabolites, Antineoplastic | 1 | 2017 | 99 | 0.16 | Why? |
| Virus Cultivation | 1 | 2020 | 579 | 0.16 | Why? |
| Antigen-Antibody Reactions | 1 | 2018 | 616 | 0.16 | Why? |
| Mitochondrial Proteins | 1 | 2017 | 152 | 0.16 | Why? |
| Hemagglutinins, Viral | 1 | 2017 | 176 | 0.16 | Why? |
| Sampling Studies | 1 | 2017 | 386 | 0.16 | Why? |
| Nucleoproteins | 1 | 2018 | 223 | 0.16 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 343 | 0.16 | Why? |
| Madin Darby Canine Kidney Cells | 4 | 2019 | 640 | 0.15 | Why? |
| Ebola Vaccines | 1 | 2017 | 126 | 0.15 | Why? |
| RNA, Small Interfering | 2 | 2017 | 817 | 0.15 | Why? |
| Blood Safety | 1 | 2021 | 459 | 0.15 | Why? |
| Chromatography, Affinity | 1 | 2017 | 310 | 0.15 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 243 | 0.15 | Why? |
| Vero Cells | 3 | 2021 | 14117 | 0.15 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 347 | 0.15 | Why? |
| Animals | 16 | 2021 | 78931 | 0.15 | Why? |
| Chickens | 2 | 2018 | 1010 | 0.15 | Why? |
| Bacteriological Techniques | 1 | 2017 | 239 | 0.15 | Why? |
| Virus Latency | 1 | 2017 | 251 | 0.14 | Why? |
| Pyridones | 1 | 2020 | 738 | 0.14 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1014 | 0.14 | Why? |
| Mass Spectrometry | 1 | 2020 | 1165 | 0.14 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.14 | Why? |
| RNA Interference | 1 | 2017 | 534 | 0.14 | Why? |
| Mice | 9 | 2019 | 21357 | 0.13 | Why? |
| Antigen-Presenting Cells | 1 | 2014 | 206 | 0.13 | Why? |
| Furin | 1 | 2020 | 1054 | 0.13 | Why? |
| Mice, Nude | 3 | 2018 | 340 | 0.12 | Why? |
| Cryoelectron Microscopy | 1 | 2020 | 2372 | 0.12 | Why? |
| Gene Regulatory Networks | 1 | 2017 | 820 | 0.12 | Why? |
| Transcription, Genetic | 1 | 2018 | 1326 | 0.12 | Why? |
| Virus Inactivation | 1 | 2021 | 1139 | 0.11 | Why? |
| Lipopolysaccharide Receptors | 1 | 2014 | 357 | 0.11 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.11 | Why? |
| Antigen Presentation | 1 | 2014 | 524 | 0.11 | Why? |
| Dogs | 4 | 2019 | 2529 | 0.11 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.10 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.10 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.10 | Why? |
| Amino Acid Sequence | 2 | 2018 | 6049 | 0.10 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.10 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.10 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.10 | Why? |
| Protein Conformation | 1 | 2020 | 4386 | 0.10 | Why? |
| Pyrazines | 1 | 2020 | 1783 | 0.10 | Why? |
| Sputum | 1 | 2017 | 1720 | 0.10 | Why? |
| Amides | 1 | 2020 | 1864 | 0.10 | Why? |
| Models, Molecular | 2 | 2020 | 7616 | 0.09 | Why? |
| Arthritis, Experimental | 1 | 2008 | 44 | 0.09 | Why? |
| A549 Cells | 3 | 2019 | 2066 | 0.09 | Why? |
| HEK293 Cells | 2 | 2018 | 8394 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.09 | Why? |
| China | 9 | 2021 | 50654 | 0.08 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.08 | Why? |
| Interleukin-4 | 1 | 2008 | 367 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.08 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 245 | 0.08 | Why? |
| Humans | 26 | 2021 | 930598 | 0.08 | Why? |
| Cell Proliferation | 3 | 2018 | 1973 | 0.07 | Why? |
| Disease Models, Animal | 2 | 2020 | 10998 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 7868 | 0.07 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.07 | Why? |
| Prostatic Neoplasms | 1 | 2017 | 1637 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Cell Movement | 2 | 2018 | 695 | 0.07 | Why? |
| Genetic Therapy | 1 | 2008 | 409 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.06 | Why? |
| Influenza, Human | 2 | 2019 | 10779 | 0.06 | Why? |
| HIV-1 | 1 | 2017 | 3365 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Immunogenicity, Vaccine | 1 | 2017 | 4624 | 0.06 | Why? |
| Virus Replication | 3 | 2018 | 14331 | 0.06 | Why? |
| RNA, Viral | 5 | 2021 | 32276 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2018 | 2941 | 0.06 | Why? |
| Limit of Detection | 2 | 2020 | 2698 | 0.05 | Why? |
| T-Lymphocytes | 2 | 2017 | 6670 | 0.05 | Why? |
| Phosphoproteins | 2 | 2021 | 4346 | 0.05 | Why? |
| Codon | 1 | 2020 | 287 | 0.05 | Why? |
| Immunoglobulin Isotypes | 1 | 2021 | 308 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Neoplasms | 2 | 2018 | 17251 | 0.05 | Why? |
| Female | 12 | 2021 | 380317 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.04 | Why? |
| Cytoskeleton | 1 | 2018 | 99 | 0.04 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.04 | Why? |
| Infant | 2 | 2021 | 30274 | 0.04 | Why? |
| Polysorbates | 1 | 2018 | 125 | 0.04 | Why? |
| Serial Passage | 1 | 2017 | 126 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2020 | 907 | 0.04 | Why? |
| Heterografts | 1 | 2017 | 203 | 0.04 | Why? |
| Hemagglutinins | 1 | 2018 | 143 | 0.04 | Why? |
| Polyproteins | 1 | 2020 | 814 | 0.04 | Why? |
| Squalene | 1 | 2018 | 196 | 0.04 | Why? |
| Integrins | 1 | 2018 | 158 | 0.04 | Why? |
| Spheroids, Cellular | 1 | 2017 | 124 | 0.04 | Why? |
| Cholesterol | 1 | 2021 | 660 | 0.04 | Why? |
| Apoptosis | 2 | 2017 | 2335 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.04 | Why? |
| Anilides | 1 | 2017 | 105 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Poultry | 1 | 2018 | 437 | 0.04 | Why? |
| Virulence Factors | 1 | 2019 | 338 | 0.04 | Why? |
| Cell Adhesion | 1 | 2017 | 230 | 0.04 | Why? |
| Phylogeny | 3 | 2020 | 13341 | 0.04 | Why? |
| Evolution, Molecular | 2 | 2020 | 3691 | 0.04 | Why? |
| Cell Adhesion Molecules | 1 | 2018 | 472 | 0.04 | Why? |
| Carcinogenesis | 1 | 2017 | 236 | 0.04 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2016 | 8843 | 0.04 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.03 | Why? |
| Chick Embryo | 1 | 2015 | 249 | 0.03 | Why? |
| Injections, Intramuscular | 1 | 2017 | 800 | 0.03 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2017 | 242 | 0.03 | Why? |
| MAP Kinase Signaling System | 1 | 2017 | 360 | 0.03 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.03 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.03 | Why? |
| Adaptation, Physiological | 1 | 2017 | 359 | 0.03 | Why? |
| Multilocus Sequence Typing | 1 | 2015 | 264 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| DNA Primers | 1 | 2018 | 1170 | 0.03 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Quinolines | 1 | 2017 | 403 | 0.03 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
| Drug Monitoring | 1 | 2020 | 1408 | 0.03 | Why? |
| Calcium | 1 | 2017 | 708 | 0.03 | Why? |
| Adult | 6 | 2021 | 244371 | 0.03 | Why? |
| HLA-DR Antigens | 1 | 2014 | 563 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.03 | Why? |
| Sequence Analysis, RNA | 1 | 2020 | 2290 | 0.03 | Why? |
| Blood Transfusion | 1 | 2021 | 1399 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Risk Factors | 2 | 2017 | 71621 | 0.03 | Why? |
| Proteome | 1 | 2021 | 1812 | 0.03 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.03 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.03 | Why? |
| Base Sequence | 1 | 2018 | 3581 | 0.03 | Why? |
| Metformin | 1 | 2017 | 640 | 0.02 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Aged, 80 and over | 2 | 2017 | 88759 | 0.02 | Why? |
| Genes, Viral | 1 | 2015 | 1428 | 0.02 | Why? |
| Myocardium | 1 | 2021 | 2323 | 0.02 | Why? |
| Viral Tropism | 1 | 2017 | 1329 | 0.02 | Why? |
| Mice, Inbred DBA | 1 | 2008 | 56 | 0.02 | Why? |
| Synovial Membrane | 1 | 2008 | 72 | 0.02 | Why? |
| Africa | 1 | 2017 | 2986 | 0.02 | Why? |
| Membrane Glycoproteins | 1 | 2017 | 2273 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.02 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Virulence | 1 | 2015 | 2172 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Aged | 3 | 2021 | 215776 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Cytokines | 1 | 2008 | 15010 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| Neutralization Tests | 1 | 2018 | 6698 | 0.02 | Why? |
| Th2 Cells | 1 | 2008 | 680 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2017 | 3614 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Zoonoses | 1 | 2016 | 3034 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Models, Theoretical | 1 | 2021 | 6659 | 0.01 | Why? |
| Th1 Cells | 1 | 2008 | 1228 | 0.01 | Why? |
| Adenoviridae | 1 | 2008 | 1151 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Antigens, Viral | 1 | 2018 | 6298 | 0.01 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Genetic Vectors | 1 | 2008 | 1600 | 0.01 | Why? |
| Fever | 1 | 2017 | 7795 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Interferon-gamma | 1 | 2008 | 2711 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Gene Expression | 1 | 2008 | 3332 | 0.01 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.01 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2016 | 12361 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Lung | 1 | 2018 | 31049 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2016 | 27595 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |